Targeting residual inflammatory risk as a strategy to lower CV risk - PACE-CME

Targeting residual inflammatory risk as a strategy to lower CV risk

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Careful implementation of PCSK9 inhibitors in clinical practice
Careful implementation of PCSK9 inhibitors in clinical practice
CSI 2016 ESC
Careful implementation of PCSK9 inhibitors in clinical practice
- Prof. dr. Terje Pedersen
Possible approaches in precision medicine for secundary CV prevention
Possible approaches in precision medicine for secundary CV prevention
CSI 2016 ESC
Possible approaches in precision medicine for secundary CV prevention
- Dr. Noel Bairey Merz
To SPRINT or not to SPRINT to a lower blood pressure target?
To SPRINT or not to SPRINT to a lower blood pressure target?
CSI 2016 ESC
To SPRINT or not to SPRINT to a lower blood pressure target?
Understanding why patients do not take their medication and stimulating adherence
Understanding why patients do not take their medication and stimulating adherence
CSI 2016 ESC
Understanding why patients do not take their medication and stimulating adherence
- Prof. Robert Horne